Ambys Medicines
Marianne Rayos has worked in the accounting field since 1999. Marianne began their career as a Senior Accountant at Axys Pharmaceuticals, Inc., which was acquired by Celera Genomics, Inc. in 1999. Marianne then moved to Sherman Clay & Co., Inc. in 2002, where they held the role of Accounting Manager. In 2006, they joined Nuvelo, Inc., which was acquired by ARCA Biopharma, Inc., and worked as a Senior Accountant. Marianne also held a Senior Accountant (Contract) role at Saba Software in 2009. Later that same year, they moved to Natus Medical Incorporated, where they worked as a Senior Accountant/Analyst. In 2015, they joined Anacor Pharmaceuticals, which was acquired by Pfizer, Inc., and worked as a Senior Accountant. Finally, in 2019, they began their current role as an Accounting Manager at Ambys Medicines.
Marianne Rayos has a Bachelor's Degree from the University of San Francisco.
This person is not in any teams
Ambys Medicines
Ambys Medicines is a biotechnology company focused on discovering and developing regenerative and restorative therapies for people with advanced liver disease. Founded by world-renowned experts in liver disease and regenerative medicine, Ambys is pioneering the application of novel modalities including cell and gene therapy, and gain-of-function drug therapy, to meet the urgent need for treatments that have the potential to restore liver function and prevent the progression to liver failure across multiple liver diseases that are untreatable or poorly treated today.